Symbol="VIGL"
AssetType="Common Stock"
Name="Vigil Neuroscience Inc"
Description="Vigil Neuroscience, Inc., a biotechnology company, discovers and develops novel therapies that take advantage of advances in the science and human genetics of microglia. The company is headquartered in Cambridge, Massachusetts."
CIK="1827087"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="1 BROADWAY, 7TH FLOOR, SUITE 07-300, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="271207000"
EBITDA="-74202000"
PERatio="None"
PEGRatio="None"
BookValue="4.804"
DividendPerShare="0"
DividendYield="0"
EPS="-2.26"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.254"
ReturnOnEquityTTM="-0.431"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.26"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="19.71"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="2.12"
EVToRevenue="-"
EVToEBITDA="-3.705"
Beta="None"
num_52WeekHigh="16.77"
num_52WeekLow="6.29"
num_50DayMovingAverage="9.27"
num_200DayMovingAverage="10.8"
SharesOutstanding="35685100"
DividendDate="None"
ExDividendDate="None"
symbol="VIGL"
open="7.92"
high="8.04"
low="7.55"
price="7.60"
volume="16257.00"
latest_trading_day="2023-08-01"
previous_close="8.14"
change="-0.54"
change_percent="-6.6339%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="99"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="1"
Volume_recent_avg="58930"
Change_recent_avg="0.01"
Delta_recent_avg="0.83"
Variance_recent_avg="0.41"
Change_ratio_recent_avg="-0.04"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="1"
Aroon_momentum_negative="99"
image_negative_thumbnail_id_1="103"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0073.jpeg"
image_negative_thumbnail_id_2="100"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0076.jpeg"
image_neutral_thumbnail_id_1="566"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_neutral_thumbnail_id_2="524"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0075.jpeg"
image_positive_thumbnail_id_1="691"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0017.jpeg"
image_positive_thumbnail_id_2="993"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0155.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
